Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 16Myelodysplastic Syndromes 3Leukemia, Monocytic, Acute 3Leukemia 3Recurrence 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Myeloproliferative Disorders 2Thrombocythemia, Essential 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Lymphoid 1Leukemia, Erythroblastic, Acute 1Leukemia, Biphenotypic, Acute 1Disease 1Congenital Abnormalities 1Burkitt Lymphoma 1

Interventions

Cytarabine 21fludarabine phosphate 8Busulfan 8Daunorubicin 7Peripheral Blood Stem Cell Transplantation 6Mitoxantrone 6Idarubicin 6Methotrexate 5Gemtuzumab 5Filgrastim 5Etoposide 5Clofarabine 5tipifarnib 4Whole-Body Irradiation 4Vorinostat 4Tacrolimus 4Cyclosporine 4Cyclophosphamide 4Antilymphocyte Serum 4sargramostim 3alvocidib 3Observation 3Mycophenolic Acid 3Flow Cytometry 3Decitabine 3Cytogenetic Analysis 3Azacitidine 3aldesleukin 2Pravastatin 2In Situ Hybridization, Fluorescence 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Leukemia, Megakaryoblastic, Acute × CPX-351 × Clear all
NCT02019069 2019-01-22

CPX-351 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

Stanford University

Phase 2 Completed
11 enrolled 17 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡